With the aging of the population, the need for treatments of
ocular diseases and disorders has become more critical than ever. Increasingly
high incidences of age-related macular degeneration (AMD), glaucoma, diabetic
retinopathy and ocular inflammatory diseases demand better, more effective and
innovative treatments. If we are to maintain the quality of life for these
people, the preservation of vision is critical. This conference will address drug
targeting, novel and emerging treatments, along with novel and emerging
pathways that hold promise in treating these crippling conditions.
Topics Include:
- New disease pathways
- Alternative drugs
- Anti-inflammatories
- Biologics
- Combination therapies
- Novel therapeutics
- Anti-angiogenics
- Kinase inhibitors
Hear Focused Sessions On:
- Science for Success
- Biologic Therapies
- Targeting New or Existing Pathways in Novel Ways
- Novel Therapeutics
- Looking to the Future
- New Therapeutic Targets
- Studies in Success
- Targeting Lesser-Used Pathways